Lukes AS

No ORCID on file · 4 papers in corpus · active 2014-2022

Study types

  • article 1

Condition tags

  • adenomyosis 1
2022
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Obstetrics and gynecology ·doi:10.1097/aog.0000000000004988

ObjectiveIn the LIBERTY 1 and LIBERTY 2 placebo-controlled trials, once-daily relugolix combination therapy reduced menstrual blood loss volume and pain in women with heavy menstrual bleeding associated with uterine leiomyomas and was well …

2019
12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids.
International journal of women's health ·doi:10.2147/ijwh.s201912

ObjectiveThe prospective SONATA pivotal Investigational Device Exemption (IDE) trial was performed in the United States (US) and Mexico to examine the safety and effectiveness of transcervical fibroid ablation (TFA) in the treatment of symp…

article 2017
Experience of Symptoms and Disease Impact in Patients with Adenomyosis
The patient ·doi:10.1007/s40271-017-0284-2

BACKGROUND: Adenomyosis is a poorly understood, benign disease of the uterus. OBJECTIVE: In this study, patient interviews were conducted to characterize the symptoms and impact of adenomyosis. METHODS: This was a cross-sectional study in w…

2014
Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs.
ClinicoEconomics and outcomes research : CEOR ·doi:10.2147/ceor.s67888

BackgroundWomen with abnormal uterine bleeding (AUB) may be treated surgically with hysterectomy or global endometrial ablation (GEA), an outpatient procedure. We compared the costs and clinical outcomes of these surgical procedures for AUB…